Feb 3, 2021 Foresee Home AMD Monitoring Program Don’t leave your vision to chance: 94% of patients using ForeseeHome maintained driving vision (20/40 or better) after their dry Macular Degeneration changed to wet. Ask us if ForeseeHome is right for you. Please click here for more information about this program:https://www.foreseehome.com/ #DetectEarly #TreatEarly #ForeseeHome #MacularDegeneration Sep 9, 2024 AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME AiViva Biopharma completes enrollment in Phase 1 clinical trial of AIV007 for AMD, DME Aug 21, 2024 AOA urges eye care provider consultation before use, purchase of MSM eye drops AOA urges eye care provider consultation before use, purchase of MSM eye drops Aug 15, 2024 Prevalence of AMD-related vision loss expected to increase as population ages Prevalence of AMD-related vision loss expected to increase as population ages